Anti-aging Peptides

SS-31 (Elamipretide)

Catalog #: SS31

SS-31 is a mitochondria-targeted tetrapeptide that binds cardiolipin on the inner mitochondrial membrane. Optimizes electron transport chain function and reduces oxidative stress at its source for aging and mitochondrial research.

Catalog Number SS31
Sequence D-Arg-Dmt-Lys-Phe-NH₂
Target Cardiolipin (inner mitochondrial membrane)
Concentration >1,000× in mitochondria vs. extracellular

Available SKUs

Model Specification MOQ
2S10 10mg / 10ml 1 vial
2S50 50mg / 10ml 1 vial
Ships within 5-7 business days
Certificate of Analysis included
Quality guaranteed

Product Overview

SS-31 is a mitochondria-targeted tetrapeptide that binds cardiolipin on the inner mitochondrial membrane. Optimizes electron transport chain function and reduces oxidative stress at its source for aging and mitochondrial research.

Research Applications

  • Mitochondria-targeted tetrapeptide (>1,000× IMM enrichment)
  • Selectively binds cardiolipin — stabilizes ETC supercomplexes
  • Reduces electron leak and mitochondrial superoxide production
  • Reverses age-related mitochondrial dysfunction in published studies
  • Studied in cardiac, renal, skeletal muscle, and neural models

Key Features

  • ≥99% purity confirmed by RP-HPLC and ESI-MS
  • For laboratory research use only

Technical Support

Our team of product experts is available to assist with your research needs.

Contact Support

OEM Services

Need modifications or larger quantities? Request a custom synthesis quote.

Request Custom
Catalog Number SS31
Sequence D-Arg-Dmt-Lys-Phe-NH₂
Target Cardiolipin (inner mitochondrial membrane)
Concentration >1,000× in mitochondria vs. extracellular
Molecular Weight ~640.8 Da
Form Lyophilized powder
Purity ≥99% (RP-HPLC)
Storage -20°C, desiccated

Need OEM or a Custom Configuration?

We support practical, production-ready customization for peptides, sequences, and modifications. Share your synthesizer type, dimensions, modifications preference, and packaging needs—our team will confirm feasibility and lead time.